Xcout Intel
WUXI XDC
WuXi XDC Cayman Inc. operates as an investment holding company and a global contract research, development, and manufacturing organization (CRDMO), with operations spanning China, North America, Europe, and other international regions. The company's expertise covers the entire lifecycle, from discovery and research to development and manufacturing, of biopharmaceutical products. Specifically, it focuses on antibody-drug conjugates (ADCs), various bioconjugates, monoclonal antibody intermediates, and the crucial payload-linkers integral to bioconjugate synthesis. Founded in 2013 and headquartered in Wuxi, China, WuXi XDC Cayman Inc. is a subsidiary of WuXi Biologics (Cayman) Inc.
Subscribe to see WUXI XDC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
WUXI XDC at a glance
WUXI XDC is a biotech company headquartered in Wuxi, China. It is publicly listed (02268) with a market capitalisation of $10.5B. Xcout tracks 1 named person at WUXI XDC, including Jimmy Li (CEO).
WUXI XDC leadership
- Jimmy LiCEO
Get WUXI XDC's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on WUXI XDC in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access